scholarly journals Pediatric Psychopharmacological Research in the Post EU Regulation 1901/2006 Era

2014 ◽  
Vol 42 (6) ◽  
pp. 441-449 ◽  
Author(s):  
Christine Schmäl ◽  
Katja Becker ◽  
Ruth Berg ◽  
Michael Brünger ◽  
Gerd Lehmkuhl ◽  
...  
Keyword(s):  
Children And Adolescents ◽  
Adolescent Psychiatry ◽  
Age Groups ◽  
Child And Adolescent ◽  
German Society ◽  
Child And Adolescent Psychiatry ◽  
The European Union ◽  
Medicinal Products ◽  
Pediatric Populations ◽  
Areas Of Concern

Although the use of psychotropic medications in child and adolescent psychiatry in Germany is on the increase, most compounds are in fact prescribed “off-label” because of a lack of regulatory approval in these age groups. In 2007, the European Parliament introduced Regulation 1901/2006 concerning medicinal products in pediatric populations, with a subsequent amendment in the form of Regulation 1902/2006. The main aim of this legislation was to encourage research and clinical trials in children and adolescents, and thus promote the availability of medications with marketing authorization for these age groups. Furthermore, initiatives such as the European 7th Framework Program of the European Union now offer substantial funding for pediatric pharmacological research. At a recent Congress of the German Society for Child and Adolescent Psychiatry and Psychotherapy (DGKJP), experts from the field and the pharmaceutical industry held a symposium with lay representatives in order to discuss attitudes toward, and experience with, pediatric psychopharmacology research in Germany since 2007. Several areas of concern were identified. The present paper derives from that symposium and provides an overview of these opinions, which remain crucial to the field. A wider discussion of how to facilitate psychopharmacological research in Germany in order to optimize the treatment and welfare of children and adolescents with psychiatric disorders is now warranted.

scholarly journals The European Society for Child and Adolescent Psychiatry (ESCAP): history and challenges for the future

2005 ◽  
Vol 2 (8) ◽  
pp. 19-22
Author(s):  
Ernest Caffo ◽  
Luisa Strik Lievers
Keyword(s):  
European Union ◽  
Children And Adolescents ◽  
Adolescent Psychiatry ◽  
European Society ◽  
Geographical Area ◽  
Child And Adolescent ◽  
Child And Adolescent Psychiatry ◽  
The European Union ◽  
The Future

The European Society for Child and Adolescent Psychiatry (ESCAP) assembles 29 national societies of child and adolescent psychiatry of several countries belonging to the European Union or to its cultural and geographical area. It is the only association that gathers European psychiatrists who work with children and adolescents.

scholarly journals Overcoming traps and challenges in child and adolescent psychiatry

2021 ◽  
pp. 9-9
Author(s):  
Milica Pejovic-Milovancevic ◽  
Roberto Grujicic ◽  
Sanja Stupar ◽  
Minja Ninkovic
Keyword(s):  
Adolescent Psychiatry ◽  
Age Groups ◽  
Child And Adolescent ◽  
Healthcare Systems ◽  
Child And Adolescent Psychiatry ◽  
Successful Development ◽  
Professional Societies ◽  
Good Mental Health ◽  
The World ◽  
Psychiatric Conditions

Appropriate healthcare and psychological support for children and adolescents is essential for the successful development and good mental health. Unfortunately, this is often a neglected element in the healthcare systems around the world. It is known that approximately half of all adult psychiatric disorders start under the age of 14 and that the prevalence of child and adolescent-onset psychiatric conditions is increasing. The real reason for this increase remains unclear but it demands our attention as does the care of affected children, adolescents and their families. Transitions between different age groups need to be made easily navigable for the patients and their families. Many challenges in child and adolescent psychiatry are present, especially in developing countries such as in Serbia. A possible solution for overcoming these challenges is uniting of child and adolescent professional societies from all over the world. These societies should work together to develop unified strategies for diagnosis, treatment and support of children affected by psychiatric conditions. By working closely with pediatricians, family physicians, psychologists, nurses and other professionals, child and adolescent psychiatry can use knowledge and skills to support practice while teaching other professionals how to optimize the utilization of child and adolescent psychiatry services

scholarly journals Profile of sleep pattern, psychiatric comorbidity and problematic electronic gadget use in children and adolescents with autism and ADHD

BJPsych Open ◽  
2021 ◽  
Vol 7 (S1) ◽  
pp. S34-S34
Author(s):  
Darpan Kaur ◽  
Sanay Patani ◽  
Rishab Verma ◽  
Rakesh Ghildiyal
Keyword(s):  
Children And Adolescents ◽  
Adolescent Psychiatry ◽  
Psychiatric Comorbidity ◽  
Child And Adolescent ◽  
Child And Adolescent Psychiatry ◽  
Policy Implications ◽  
Sleep Pattern ◽  
Psychiatry Clinic ◽  
Oppositional Defiant ◽  
Adolescents With Autism

AimsTo assess the profile of Sleep pattern, Psychiatric comorbidity and problematic electronic gadget use and explore demographic factors and correlations in children and adolescents with ADHD and Autism.Hypothesis: There are statistically significant problems and associations across sleep pattern, psychiatric comorbidity and gadget use in children and adolescents with autism and ADHD.BackgroundLiterature highlights increasing global trends and emerging concerns over the problematic use of electronic gadgets and sleep related problems in children and adolescents with autism and ADHD. There is sparse literature on the profile of sleep patterns, psychiatry comorbidity and problematic gadget use in children and adolescents with autism and ADHD from developing countries.MethodThis was an observational study conducted at the Child and Adolescent Psychiatry Clinic, Department of Psychiatry at a tertiary care Institution under the STS ICMR Project 2019 with Institutional Ethics Clearance. Apriori Sample size calculated was 70. Children and adolescents diagnosed with autism or ADHD as per ICD 10 criteria, fulfilling the inclusion criteria and willing to participate in the study were included. Informed consent was obtained from caregivers. Sleep Disturbance Scale for Children, Self Designed Parent based Problematic Electronic Gadget Use Scale, Vanderbilt ADHD scale, Indian scale for Assessment of Autism and the Child and Adolescent Psychiatry Clinic structured Performa were the tools for data collection. The results were analyzed with descriptive tests, chi square test and multiple logistic regressions using SPSS.ResultMean age of the sample was 9.1 years and majority (57%) were boys. Forty nine patients had ADHD and 21 patients had Autism. Problematic gadget use was higher in children ranging from 6 to 15 years of age and 12.8% had severe levels of problematic gadget use. 34.3% patients experienced severe problems in initiating and maintaining sleep. Oppositional-Defiant disorder was the most common comorbidity, predominantly inattentive type (76.4%) was the most common subtype of ADHD and mild autism (54.3%) was the most common type of autism in the sample. There were statistically significant associations (p < 0.05) between age and gadget use; hyperactive subtype of ADHD and problems with initiating and maintaining sleep and ADHD subtype, sex profile and problematic gadget use.ConclusionWe conclude that sleep problems, psychiatric comorbidity and problematic gadget use are prevalent with statistically significant associations in children and adolescents with autism and ADHD as per our study findings. Our study has relevant clinical, research and policy implications.

scholarly journals Can we – and should we – have a ‘Europsychiatry’ for children and adolescents? The work of the UEMS Section and Board for Child and Adolescent Psychiatry/Psychotherapy

2004 ◽  
Vol 1 (6) ◽  
pp. 19-21
Author(s):  
Peter Hill ◽  
Aribert Rothenberger
Keyword(s):  
Children And Adolescents ◽  
Adolescent Psychiatry ◽  
Child And Adolescent ◽  
Child And Adolescent Psychiatry ◽  
Medical Specialists

Since 1994, child and adolescent psychiatry has been a distinct specialty, separate from psychiatry, within the Union of European Medical Specialists (UEMS). It has a slightly curious title, of which more later. It has proved a successful arena for promoting training, and this in turn has led to a developing European view of what exactly child and adolescent psychiatry is, and how it can be practised. This article tries to reflect this.

scholarly journals Prescribing antipsychotics in child and adolescent psychiatry: guideline adherence

2020 ◽  
Vol 29 (12) ◽  
pp. 1717-1727 ◽  
Author(s):  
Mariken Dinnissen ◽  
Andrea Dietrich ◽  
Judith H. van der Molen ◽  
Anne M. Verhallen ◽  
Ynske Buiteveld ◽  
...  
Keyword(s):  
Children And Adolescents ◽  
Adolescent Psychiatry ◽  
Psychosocial Interventions ◽  
Child And Adolescent ◽  
Autism Spectrum ◽  
Child And Adolescent Psychiatry ◽  
Psychosocial Treatment ◽  
Antipsychotic Treatment ◽  
Concomitant Treatment ◽  
Off Label

Abstract Antipsychotics are often prescribed to children and adolescents, mostly off-label. We aimed to assess adherence to recommendations of guidelines for antipsychotic prescription. We reviewed 436 medical records from 155 clinicians from 26 clinics within three Dutch child and adolescent psychiatry organizations (n = 398 outpatient, n = 38 inpatient care). We assessed target symptoms, diagnostic process, prior and concomitant treatment, and consideration of contra-indications. Multiple logistic regression assessed the role of age, sex, and psychiatric diagnosis on adherence to three main recommendations: to (1) prescribe antipsychotics only after other treatments proved insufficient, (2) always combine antipsychotics with psychosocial interventions, and (3) not prescribe multiple antipsychotics simultaneously. Most patients received off-label antipsychotics. Main target symptoms were inattention/hyperactivity (25%), aggression (24%), and other disruptive behaviors (41%). Most patients underwent diagnostic evaluation before the first prescription; however, screening of contra-indications was low (0.2–19%). About 84% had previously received psychosocial treatment and 48% other psychoactive medication, but 9% had not received any treatment. Notably, only 37% continuously received concomitant psychosocial treatment. Simultaneous use of multiple antipsychotics occurred in 3.2%. Younger children were at higher risk of non-adherence to guideline recommendations regarding prior and concomitant treatment, children with autism spectrum disorder or attention-deficit/hyperactivity disorder more likely not to receive concomitant psychosocial treatment. Sex did not significantly affect adherence. Our findings implicate insufficient adherence to important recommendations regarding antipsychotic use in children and adolescents. Especially younger children are at higher risk of receiving suboptimal care. There is an urgency to consistently offer psychosocial interventions during antipsychotic treatment.

Sign in / Sign up

Export Citation Format

Share Document